Celcuity Inc. (NASDAQ:CELC) Receives Average Recommendation of “Buy” from Analysts

Celcuity Inc. (NASDAQ:CELC) has received an average rating of “Buy” from the seven analysts that are presently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $29.17.

Several brokerages have issued reports on CELC. Needham & Company LLC reissued a “buy” rating and issued a $23.00 price objective on shares of Celcuity in a research note on Friday, November 15th. HC Wainwright reissued a “buy” rating and set a $27.00 price target on shares of Celcuity in a report on Friday, November 15th. Lifesci Capital initiated coverage on Celcuity in a report on Monday, August 26th. They issued an “outperform” rating and a $27.00 price objective on the stock. Finally, Stifel Nicolaus increased their target price on Celcuity from $39.00 to $42.00 and gave the stock a “buy” rating in a research note on Monday, October 7th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. State Street Corp grew its holdings in shares of Celcuity by 152.2% in the 3rd quarter. State Street Corp now owns 1,107,415 shares of the company’s stock worth $16,512,000 after acquiring an additional 668,318 shares during the period. Samlyn Capital LLC boosted its position in Celcuity by 92.4% during the second quarter. Samlyn Capital LLC now owns 1,326,953 shares of the company’s stock worth $21,735,000 after purchasing an additional 637,190 shares in the last quarter. Braidwell LP grew its holdings in Celcuity by 71.2% in the third quarter. Braidwell LP now owns 884,306 shares of the company’s stock valued at $13,185,000 after purchasing an additional 367,663 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Celcuity by 226.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 221,671 shares of the company’s stock valued at $3,305,000 after buying an additional 153,712 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Celcuity by 27.6% during the 3rd quarter. Geode Capital Management LLC now owns 630,369 shares of the company’s stock worth $9,401,000 after buying an additional 136,518 shares during the last quarter. 63.33% of the stock is owned by hedge funds and other institutional investors.

Celcuity Trading Down 0.8 %

NASDAQ:CELC opened at $12.00 on Friday. Celcuity has a 12-month low of $11.51 and a 12-month high of $22.19. The company has a current ratio of 10.35, a quick ratio of 10.36 and a debt-to-equity ratio of 0.65. The stock’s 50 day simple moving average is $14.14 and its 200-day simple moving average is $15.40. The firm has a market cap of $445.56 million, a P/E ratio of -4.60 and a beta of 0.74.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.